The Association of Serum Estradiol Level with the Susceptibility and Clinicopathological Features of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
SHERWEET M. AHMED, M.D., N., SHADY E. SHAKER, M.D., M. (2020). The Association of Serum Estradiol Level with the Susceptibility and Clinicopathological Features of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. EKB Journal Management System, 88(March), 173-180. doi: 10.21608/mjcu.2020.93975
NEARMEEN M. RASHAD, M.D.; SHERWEET M. AHMED, M.D.; MAHA A. FATHY, M.D.; SHADY E. SHAKER, M.D.. "The Association of Serum Estradiol Level with the Susceptibility and Clinicopathological Features of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease". EKB Journal Management System, 88, March, 2020, 173-180. doi: 10.21608/mjcu.2020.93975
SHERWEET M. AHMED, M.D., N., SHADY E. SHAKER, M.D., M. (2020). 'The Association of Serum Estradiol Level with the Susceptibility and Clinicopathological Features of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease', EKB Journal Management System, 88(March), pp. 173-180. doi: 10.21608/mjcu.2020.93975
SHERWEET M. AHMED, M.D., N., SHADY E. SHAKER, M.D., M. The Association of Serum Estradiol Level with the Susceptibility and Clinicopathological Features of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. EKB Journal Management System, 2020; 88(March): 173-180. doi: 10.21608/mjcu.2020.93975